March 17, 2026| Regulatory news and notifications| Tenzin Wangmo
... Read More → Notification-Revised Market Authorization Guidelines.
March 16, 2026| Regulatory news and notifications| Tenzin Wangmo
... Read More → Regulatory Notification on Publication of Irrational FDC
... Read More → Regulatory Notification on publication of Bioequivalence and Biowaiver list
March 12, 2026| Regulatory news and announcements| Tenzin Wangmo
The Medical Products Division of the Bhutan Food and Drug Authority (BFDA) is pleased to present the draft... Read More → Public Consultation on “Guideline for Post-market and market surveillance of medical device:Management of adverse events”
September 16, 2026
September 9, 2026
August 21, 2026
August 14, 2026
Accessibility Tools
